Literature DB >> 20017122

Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules.

Wenkui Li1, Francis L S Tse.   

Abstract

The collection of whole blood samples on paper, known as dried blood spot (DBS), dates back to the early 1960s in newborn screening for inherited metabolic disorders. DBS offers a number of advantages over conventional blood collection. As a less invasive sampling method, DBS offers simpler sample collection and storage and easier transfer, with reduced infection risk of various pathogens, and requires a smaller blood volume. To date, DBS-LC-MS/MS has emerged as an important method for quantitative analysis of small molecules. Despite the increasing popularity of DBS-LC-MS/MS, the method has its limitations in assay sensitivity due to the small sample size. Sample quality is often a concern. Systematic assessment on the potential impact of various blood sample properties on accurate quantification of analyte of interest is necessary. Whereas most analytes may be stable on DBS, unstable compounds present another challenge for DBS as enzyme inhibitors cannot be conveniently mixed during sample collection. Improvements on the chemistry of DBS card are desirable. In addition to capturing many representative DBS-LS-MS/MS applications, this review highlights some important aspects of developing and validating a rugged DBS-LC-MS/MS method for quantitative analysis of small molecules along with DBS sample collection, processing and storage.

Entities:  

Mesh:

Year:  2010        PMID: 20017122     DOI: 10.1002/bmc.1367

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  71 in total

1.  Use of dried blood spots in drug development: pharmacokinetic considerations.

Authors:  Malcolm Rowland; Gary T Emmons
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

2.  Characterization of the elemental composition of newborn blood spots using sector-field inductively coupled plasma-mass spectrometry.

Authors:  Erica K Langer; Kimberly J Johnson; Martin M Shafer; Patrick Gorski; Joel Overdier; Jessica Musselman; Julie A Ross
Journal:  J Expo Sci Environ Epidemiol       Date:  2010-06-30       Impact factor: 5.563

3.  Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots.

Authors:  Andrew G Chambers; Andrew J Percy; Juncong Yang; Christoph H Borchers
Journal:  Mol Cell Proteomics       Date:  2015-09-04       Impact factor: 5.911

4.  Whole blood is the sample matrix of choice for monitoring systemic triclocarban levels.

Authors:  Nils Helge Schebb; Ki Chang Ahn; Hua Dong; Shirley J Gee; Bruce D Hammock
Journal:  Chemosphere       Date:  2012-01-23       Impact factor: 7.086

5.  Using dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies.

Authors:  Enaksha R Wickremsinhe; Everett J Perkins
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

6.  LC-MS/MS method for the simultaneous determination of tenofovir, emtricitabine, elvitegravir and rilpivirine in dried blood spots.

Authors:  Pavan Kumar Prathipati; Subhra Mandal; Christopher J Destache
Journal:  Biomed Chromatogr       Date:  2018-04-26       Impact factor: 1.902

7.  A LC-MS/MS Method for Quantifying Adenosine, Guanosine and Inosine Nucleotides in Human Cells.

Authors:  Leah C Jimmerson; Lane R Bushman; Michelle L Ray; Peter L Anderson; Jennifer J Kiser
Journal:  Pharm Res       Date:  2016-09-15       Impact factor: 4.200

8.  Why dried blood spots are an ideal tool for CYP1A2 phenotyping.

Authors:  Pieter M M De Kesel; Willy E Lambert; Christophe P Stove
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

9.  Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group.

Authors:  Christopher Evans; Mark Arnold; Peter Bryan; Jeffrey Duggan; Christopher A James; Wenkui Li; Steve Lowes; Luca Matassa; Timothy Olah; Philip Timmerman; Xiaomin Wang; Enaksha Wickremsinhe; John Williams; Eric Woolf; Patricia Zane
Journal:  AAPS J       Date:  2014-12-09       Impact factor: 4.009

Review 10.  How to optimize the evaluation and use of antibiotics in neonates.

Authors:  Evelyne Jacqz-Aigrain; Florentia Kaguelidou; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-09-01       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.